PILA PHARMA is a privately held clinical stage pharmaceutical company based in Malmö, Sweden.
PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes.

The company owns issued use-patents giving the right to treat diabetes and obesity with TRPV1 antagonists.
Our safe clinical development candidate, XEN-D0501, has entered the first clinical trials in type-2 diabetic patients in 2017.

Pila_Logo_Orang-2x

Investor presentation at ‘Next Big Thing’ (by Blasieholmen Investment Group)
Moderna Museet, Stockholm, Sweden

Watch the presentation here
Direct link to presentation here

(02-Dec-2016)
pila_modernamuseet
Meet us at
easd

European Association for the Study of Diabetes

Lisboa, Portugal
September 11-15, 2017
easd.org

NLS_Days_2017_Main_Signature_w_date_Landscape_yellow

Nordic Life Science Days

Malmö, Sweden — Copenhagen, Denmark
September 12-14, 2017
nlsdays.com

BioJapan

BioJapan

Yokohama, Japan
October 11-13, 2017

BioJapan

Interview
Dorte_X_Gram

Uppstickaren som vill ta plats i läkemedelsindustrin.
An interview with CEO Dorte X. Gram published in ‘DI Almedalen, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here

(03-Jul-2017)
affarslivet

We are proud to be on the cover of the June 2017 issue of Affärslivet Norden, Medicine and Science magazine that focuses on innovation.
The magazine was distributed with Svenska Dagbladet.

Read the article in Swedish here
Read the magazine in Swedish here

(22-Jun-2017)
Dorte_x_Gram_Malmo

Stora förhoppningar på nytt effektivt läkemedel mot diabetes typ 2.
An interview with CEO Dorte X. Gram  published in ‘Analys Öresund’, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here
Read the magazine in Swedish here

(15-Jun-2017)
DorteX Gram

“Min uppfinning kom och hämtade tillbaka mig”
Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by Sydsvenskan, Sweden.

Read the article in Swedish here

(04-Dec-2016)
01-omslag-nordic-life-science-nr-03-2016

We are proud to be on the cover of the September 2016 issue of Nordic Life Science Magazine as representatives of Nordic Life Science companies.

Read the article here
Read the magazine here

(09-Sep-2016)

At BioEurope Spring in Stockholm in April 2016 Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by the organizers about the current status and our plans going forward.

Please find the links below:
partnering360.com

(08-Apr-2016)